Page 2 - Ventures China News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ventures china. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ventures China Today - Breaking & Trending Today

Arctic Vision Joins Forces with the University of Hong Kong Department of Ophthalmology to Discover and Develop Novel Neuroprotective Therapies for Ocular Disease


Arctic Vision Joins Forces with the University of Hong Kong Department of Ophthalmology to Discover and Develop Novel Neuroprotective Therapies for Ocular Disease
News provided by
Share this article
Share this article
SHANGHAI and HONG KONG, July 4, 2021 /PRNewswire/ Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today a new research collaboration with Prof. Christopher Leung, Head and Clinical Professor at the Department of Ophthalmology of the University of Hong Kong (HKU) for the discovery and development of novel neuroprotective therapies for glaucoma.
Glaucoma, an optic neuropathy characterized by progressive loss of retinal ganglion cells (RGCs), is the leading cause of irreversible blindness worldwide. ....

United States , Hong Kong , University Of Hong Kong , Hong Kong General , Dianna Qian , Christopher Leung , World Glaucoma Congress Young Clinician Scientist Award , Services Alliance Global Information , American Academy Of Ophthalmology Secretariat Award , Optic Nerve Diagnostics Lab , Asia Pacific Glaucoma Society Young Investigator Award , American Academy Of Ophthalmology Senior Achievement Award , Regeneration Lab , World Information Technology , University Of Hong Kong Professor Christopher Leung , Communications Technology , World Glaucoma Congress Science Award , Communications Excellence Award , Virtual Reality Lab , Department Of Ophthalmology , World Glaucoma Association Consensus Meeting , Association For Research , Lancet Glob Health , Scientist Research Award , Clinical Professor , Glaucoma Association Consensus ,

Regor Therapeutics Announces Completion of $90 Million Series B Financing


Regor Therapeutics Announces Completion of $90 Million Series B Financing
News provided by
Share this article
Share this article
SHANGHAI, Feb. 18, 2021 /PRNewswire/ Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing.
Founded in July of 2018 by a group of veteran drug hunters with extensive research and executive leadership experiences at top multinational pharmaceutical companies, Regor aims to establish world-class innovation capabilities and is committed to delivering clinically differentiated, best- and first-in-class drugs to serve patients globally.  By leveraging CARD, Computer Accelerated Rational Discovery, a proprietary enabling technology platform, the team has successfully advanced numerous discovery programs in a dramatically accelerated fashion, including from ....

United States , Hong Kong , Xiayang Qiu , Yi Shi , Randy Lin , Regor Therapeutics Group , Tamasek Holdings , Qilu Pharmaceutical Group , Computer Accelerated Rational Discovery , Lilly Asia Ventures , Loyal Valley Capital , Planting Capital , Vertex Ventures , Regor Therapeutics , Regor Therapeutic , Lilly Asia , Loyal Valley , Asia Ventures , Valley Capital , Tik Tok , Pop Mart , Influential Private Equity Firms , Drug Investor , Ting Capital , Vertex Ventures China , Ventures China ,